Simple Screening Questionnaire for Dementia

-News, Consciousness, and Pleasure simple screening questionnaires for dementia (Neucop-Q)-

Keio University Hospital Memory Clinic

http://www.hosp.keio.ac.jp/en/annai/shinryo/
http://www.hosp.keio.ac.jp/annai/shinryo/memory/
Outpatient reservations: +81(0)3-3353-1257

Related Paper:The utility of simple questions to evaluate cognitive impairment
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0233225 Yugaku Daté, Daisuke Sugiyama, Hajime Tabuchi, Naho Saito, Mika Konishi, Yoko Eguchi, Yuki Momota, Takahito Yoshizaki, Kyoko Mashima, Masaru Mimura, Jin Nakahara, and Daisuke Ito. PLOS one 2020 14 May
https://doi.org/10.1371/journal.pone.0233225

Input information below to show sensitivity, specificity, and positive predictive values for Alzheimer’s disease.
Please feel free to use this for everyday clinical use.

With the rise of the elderly population there is an increasing number of patients with reduced cognitive function, but because comprehensive neurological testing requires skill and sufficient time to perform, a simpler scale to be used by physicians and local caregivers to evaluate cognitive function is needed. Existing reports indicate that the existence of Attended With (AW), or examinations accompanied by someone, and Head-Turning Sign (HTS) indicate high sensitivity and high specificity, respectively, in regard to cognitive function decline, but at Keio University Hospital Memory Clinic, we have demonstrated that it is additionally possible to detect Alzheimer’s disease and mild cognitive impairment with high degrees of sensitivity and specificity by asking the patient the following three questions and combining them with the above methods: are you having trouble in your daily life (consciousness)? Do you have pleasure (pleasure)? Can you cite recent news (current/recent news/topics)?
This research is expected to enable simple screening of cognitive function decline not only for patients who are accompanied but solitary patients and hospitalized patients as well, and we believe it will result in treatment for patients who are out of reach for current cognitive impairment treatment.